Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms

BACKGROUND: The objective of this exploratory analysis was to characterize efficacy and onset of action of a 3-month treatment period with risperidone long-acting injection (RLAI), adjunctive to an individual's treatment regimen, in subjects with symptomatic bipolar disorder who relapsed freque...

Descripción completa

Detalles Bibliográficos
Autores principales: Macfadden, Wayne, Adler, Caleb M, Turkoz, Ibrahim, Haskins, John T, Turner, Norris, Alphs, Larry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219580/
https://www.ncbi.nlm.nih.gov/pubmed/22034906
http://dx.doi.org/10.1186/1471-244X-11-171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219580/
https://www.ncbi.nlm.nih.gov/pubmed/22034906
http://dx.doi.org/10.1186/1471-244X-11-171

Ejemplares similares